Video

ViaLase shares updates on new technology to treat glaucoma, company updates and upcoming trials

Author(s):

Kassi Jackson
Conferences|ASCRS

Tom Frinzi, executive chairman of ViaLase, a new company based in Orange County, gives an update on the company, sharing some exciting new things happening.

Related Videos
Image credit: ©Ophthalmology Times
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Wendy Lee, MD, talks about functional oculoplastics and aesthetics at EnVision Summit 2025
1 expert is featured in this series.
Lana Rifkin, MD, uveitis committee chair at EnVision Summit 2025
Related Content
Sight Sciences announces publication of 36-month analysis of OMNI Surgical System in managing primary open-angle glaucoma
January 9th 2025

Sight Sciences announces publication of 36-month analysis of OMNI Surgical System in managing primary open-angle glaucoma

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Prevent Blindness Ohio offers free glaucoma resources to patients and professionals
January 7th 2025

Prevent Blindness Ohio offers free glaucoma resources to patients and professionals

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Bausch + Lomb acquires ELIOS system, expanding glaucoma treatment options
December 11th 2024

Bausch + Lomb acquires ELIOS system, expanding glaucoma treatment options

Study highlights current and potential roles of AI in glaucoma diagnosis
December 7th 2024

Study highlights current and potential roles of AI in glaucoma diagnosis

© 2025 MJH Life Sciences

All rights reserved.